This study aimed to evaluate the association between sacubitril/valsartan and dementia-related adverse events (AEs) in geographical subpopulations using subgroup disproportionality analysis.
Seong Kyung Kim, Myeong Gyu Kim
doaj +1 more source
Antecedentes: La insuficiencia cardiaca (IC) es un síndrome clínico que suele ser consecuencia final de enfermedades cardiacas preexistentes, el uso de sacubitril-valsartán pretende reducir la mortalidad y mejorar la calidad de vida (CV).
Maricarmen Tapia-Venancio +8 more
doaj +1 more source
Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. [PDF]
Jung K, Shin JY, Kim JH.
europepmc +1 more source
Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways. [PDF]
Dong W, Li W.
europepmc +1 more source
Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial. [PDF]
Dhawan R +6 more
europepmc +1 more source
The Effect of Sacubitril/Valsartan on Mood and Cognitive Function in Patients with Heart Failure with Reduced Ejection Fraction. [PDF]
Al Kindi F +7 more
europepmc +1 more source
Efficacy of Sacubitril/Valsartan Among Heart Failure Individuals With Implanted Cardiac Defibrillators: A Systematic Review and Meta-Analysis. [PDF]
Asham H +5 more
europepmc +1 more source
Impact of Sacubitril/Valsartan on Cardiac Reverse Remodeling in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy. [PDF]
Atabekov T +5 more
europepmc +1 more source
Impact of Sacubitril/Valsartan on Cardiac Autonomic Function Assessed Using Physiological Data from Implantable Cardioverter-Defibrillators. [PDF]
Barone L +23 more
europepmc +1 more source

